Evolution of the HCV viral population from a patient with S282T detected at relapse after sofosbuvir monotherapy
Author:
Affiliation:
1. Gilead Sciences Inc.; Foster City CA USA
2. New Zealand Liver Transplant Unit; Auckland City Hospital; Auckland New Zealand
Publisher
Wiley
Subject
Virology,Infectious Diseases,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12405/fullpdf
Reference31 articles.
1. PSI-7851, a pronucleotide of beta-D-2′-deoxy-2′-fluoro-2′-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication;Lam;Antimicrob Agents Chemother,2010
2. Discovery of a beta-d-2′-deoxy-2′-alpha-fluoro-2′-beta-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus;Sofia;J Med Chem,2010
3. Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naive patients with HCV genotype 1: a randomized, 28-day, dose-ranging trial;Rodriguez-Torres;J Hepatol,2013
4. Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial;Osinusi;JAMA,2013
5. Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial;Kowdley;Lancet,2013
Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients;JHEP Reports;2024-07
2. Identification and characterization of Sofosbuvir‐resistant mutations of hepatitis C virus genotype 3a replicon;Journal of Medical Virology;2023-12
3. Expression Profiling of the Tripartite Motif Family Genes in Chronic Hepatitis C Patients;ACS Omega;2023-07-07
4. Host Versus Virus: The Genetics in HCV Infection Leading to Treatment;Hepatitis C - Recent Advances;2023-02-17
5. Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure;Journal of Hepatology;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3